Full-Spectrum Antibody & Protein Research Services
From target to candidate — integrated CRO services in antibody discovery, protein science, antibody engineering, and project management
QenovaBio is a biopharmaceutical CRO providing integrated R&D services to pharma companies, biotech firms, and research institutions worldwide. Our platform spans antibody discovery, protein science, antibody engineering, and project management — delivering customized solutions across the full antibody drug development pipeline.
From antigen design and screening through antibody generation and activity validation, we operate a closed, end-to-end workflow — ensuring standardized execution, reproducible data, and controlled project outcomes.
Our mature technology platform, standardized processes, and professional project management shorten timelines, reduce R&D risk, and improve success rates — helping clients accelerate drug development and translational research.
Milestone tracking, dynamic risk assessment, and full data traceability keep every CRO project on schedule and under control from kickoff to delivery.
Hybridoma, single B-cell sorting, and VHH nanobody platforms in one integrated service — tailored to your target type and application for rapid generation of high-affinity, high-specificity candidates.
Sequence analysis, molecular modeling, and rational design power our humanization, affinity maturation, bispecific construction, and Fc engineering services — systematically improving candidate developability.
Mammalian, prokaryotic, and insect cell expression systems cover the full workflow from protein production to functional and structural characterization, with standardized QC ensuring batch consistency.
Standardized Service Workflow
We Look Forward to Collaborating with You
From target validation to lead optimization and preclinical research, our team is ready to recommend the right solution and accelerate your R&D programs.
